BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12716042)

  • 1. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Risberg B; Ben-Baruch G; Reich R
    Cancer Metastasis Rev; 2003 Mar; 22(1):103-15. PubMed ID: 12716042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
    Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
    Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Nesland JM; Reich R
    Mol Cell Endocrinol; 2002 Feb; 187(1-2):39-45. PubMed ID: 11988310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.
    Davidson B; Goldberg I; Tell L; Vigdorchik S; Baekelandt M; Berner A; Kristensen GB; Reich R; Kopolovic J
    Clin Exp Metastasis; 2004; 21(3):191-9. PubMed ID: 15387369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
    Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
    Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
    Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
    Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
    Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
    Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Nesland JM; Berner A; Bryne M; Reich R
    Clin Exp Metastasis; 1999; 17(10):799-808. PubMed ID: 11089877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3.
    Oda N; Abe M; Sato Y
    J Cell Physiol; 1999 Feb; 178(2):121-32. PubMed ID: 10048576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.
    Afzal S; Lalani EN; Poulsom R; Stubbs A; Rowlinson G; Sato H; Seiki M; Stamp GW
    Hum Pathol; 1998 Feb; 29(2):155-65. PubMed ID: 9490275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
    Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
    Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.
    Behrens P; Rothe M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2001 Aug; 8(2):149-54. PubMed ID: 11445865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase-3.
    Horváth B; Hegyesi H; Nagy P; Falus A; Schaff Z
    Head Neck; 2005 Jul; 27(7):585-96. PubMed ID: 15887216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.